


Ask a doctor about a prescription for LEVOCETIRIZINE STADA 5 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Levocetirizine STADA 5 mg film-coated tablets EFG
Levocetirizine dihydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
The active substance of Levocetirizine Stada is levocetirizine dihydrochloride.
Levocetirizine dihydrochloride is an antiallergic medicine.
For the treatment of disease symptoms (symptoms) associated with:
Do not take Levocetirizine Stada:
Warnings and precautions
Consult your doctor or pharmacist before taking Levocetirizine Stada.
If you have any condition that makes it difficult for you to empty your urinary bladder (such as damaged spinal cord or enlarged prostate), please inform your doctor.
If you are epileptic or have a risk of convulsions, please consult your doctor as the use of levocetirizine dihydrochloride may worsen the crises.
If you are going to undergo any allergy testing, ask your doctor if you should stop taking levocetirizine dihydrochloride a few days before. This medicine may affect the results of the allergy test.
Children
Levocetirizine Stada is not recommended for use in children under 6 years of age since the film-coated tablets do not allow for dose adjustment.
Other medicines and Levocetirizine Stada
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Taking Levocetirizine Stada with food, drinks and alcohol
Caution is recommended if you take this medicine at the same time as alcohol or other agents that act on the brain.
In sensitive patients, taking levocetirizine with alcohol or other agents that act on the brain may cause additional decreased attention and decreased performance
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Some patients treated with levocetirizine dihydrochloride may experience somnolence or drowsiness, fatigue and exhaustion. If you are going to drive, perform potentially hazardous activities or use machinery, you are advised to wait and observe your response to the medication. However, in special tests performed in healthy people, no alterations in attention, reaction capacity and ability to drive were detected after taking levocetirizine at the recommended dose.
Levocetirizine Stada contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Posology:
The normal dose for adults and children from 6 years of age is one tablet per day.
Special dosing instructions for specific populations:
Patients with renal insufficiency should receive a lower dose according to the severity of their kidney disease and in children the dose will be based on body weight; the dose to be taken will be determined by your doctor.
Patients with severe kidney impairment should not take this medicine.
Patients with only hepatic insufficiency should take the normal prescribed dose.
Patients with hepatic and renal insufficiency should take a lower dose based on the severity of their kidney disease, and in children the dose will be based on body weight; the dose to be taken will be determined by your doctor.
No dose adjustment is necessary in elderly patients, provided their renal function is normal.
Use in children
Levocetirizine Stada is not recommended for use in children under 6 years of age.
How and when should you take Levocetirizine Stada?
The tablets should be swallowed whole with water and can be taken both on an empty stomach and with food.
How long should your treatment with Levocetirizine Stada last?
The duration of treatment depends on the type, duration and course of the symptoms and it is your doctor who must determine it.
If you take more Levocetirizine Stada than you should
If you take more levocetirizine dihydrochloride than you should, it may cause drowsiness in adults. In children, it may initially cause agitation and restlessness followed by drowsiness.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 915 620 420, indicating the medicine and the amount ingested.
If you forget to take Levocetirizine Stada
If you have forgotten to take levocetirizine dihydrochloride, or if you take a lower dose than prescribed by your doctor, do not take a double dose to make up for the forgotten doses; simply wait until the next scheduled intake and take the normal dose prescribed by your doctor.
If you stop taking Levocetirizine Stada
Stopping treatment should not have harmful effects. However, rarely, intense itching (pruritus) may appear when stopping levocetirizine dihydrochloride, even when these symptoms were not present at the start of treatment. The symptoms may disappear spontaneously. In some cases, the symptoms may be intense and require restarting treatment. The symptoms usually disappear when treatment is restarted.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common: may affect up to 1 in 10 people
Dry mouth, headache, fatigue, drowsiness/drowsiness
Uncommon: may affect up to 1 in 100 people
Exhaustion and abdominal pain
Frequency not known: frequency cannot be estimated from the available data
Other side effects have also been reported, such as palpitations, increased heart rate, convulsions, tingling, dizziness, syncope, tremor, dysgeusia (alteration of taste), sensation of movement, including sensation of spinning, visual disturbances, blurred vision, pain or difficulty urinating, inability to urinate, edema, pruritus (itching), rash, urticaria (swelling, redness and itching of the skin), skin eruption, shortness of breath, weight gain, muscle pain, joint pain, aggressive or agitated behavior, hallucinations, depression, insomnia, recurrent thoughts of concern with suicidal ideation, nightmares, hepatitis, abnormal liver function, vomiting, increased appetite, nausea, diarrhea, and oculogyric crisis (uncontrolled circular movements of the eyes). Intense itching (pruritus) when stopping treatment.
In case of the first signs of hypersensitivity reaction, stop taking levocetirizine dihydrochloride and see your doctor immediately. The symptoms of the hypersensitivity reaction may include: swelling of the mouth, tongue, face and/or throat, difficulty breathing or swallowing (chest tightness or wheezing), urticaria (rash on the skin), sudden decrease in blood pressure that may lead to collapse or shock, which can be fatal.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines and Health Products Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The first two digits indicate the month and the last four digits indicate the year. The expiry date is the last day of the month indicated.
Store in the original package to protect from moisture.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the SIGRE collection point at your pharmacy. Ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Levocetirizine Stada
Appearance of the product and contents of the pack
The film-coated tablets are white or almost white, oval, biconvex, and have the marking “L9CZ” engraved on one side and “5” on the other side.
They are packaged in blisters of 7, 10, 14, 20, 21, 28, 30, 90 and 100 tablets per pack and unit-dose blisters containing 30 x 1 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Laboratorio STADA, S.L.
Frederic Mompou, 5
08960 Sant Just Desvern (Barcelona)
Spain
Manufacturer:
Synthon BV
Microweg 22,
6545 Nijmegen
Netherlands
or
Synthon Hispania SL
Castelló 1, Polígono Las Salinas,
08830 Sant Boi de Llobregat
Spain
or
STADA Arzneimittel AG
Stadastrasse 2 - 18
61118 Bad Vilbel
Germany
or
LAMP SAN PROSPERO S.p.A.
Via della Pace, 25/A
41030 San Prospero (Modena)
Italy
or
STADA Arzneimittel GmbH
Muthgasse 36
A-1190 - Wien
Austria
This medicine is authorised in the Member States of the European Economic Area under the following names:
Austria  | Levocetirizin STADA 5 mg film-coated tablets  | 
Denmark  | Levocetirizin STADA 5mg, film-coated tablets  | 
Finland  | Levocetirizin STADA 5 mg, film-coated tablets  | 
Portugal  | Levocetirizina Ciclum 5 mg, tablets  | 
Spain  | Levocetirizina STADA 5 mg film-coated tablets EFG  | 
Date of last revision of this leaflet: September 2018
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of LEVOCETIRIZINE STADA 5 mg FILM-COATED TABLETS in November, 2025 is around 5.9 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for LEVOCETIRIZINE STADA 5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.